The nucleotide-binding oligomerization domain-like receptor NLRC5 is involved in IFN-dependent antiviral immune responses

Journal of Immunology

Volumn 184, Issue 4, 2010, Pages 1990-2000

  Kuenzel, Sven ^a   Till, Andreas ^a   Winkler, Michael ^b   Häsler, Robert ^a   Lipinski, Simone ^a   Jung, Sascha ^a   Grötzinger, Joachim ^a   Fickenscher, Helmut ^b   Schreiber, Stefan ^a,b   Rosenstiel, Philip ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; JANUS KINASE; NLRC5; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; SMALL INTERFERING RNA; STAT PROTEIN; UNCLASSIFIED DRUG; NLRC5 PROTEIN, HUMAN; OLIGODEOXYRIBONUCLEOTIDE; SIGNAL PEPTIDE;

ARTICLE; CELL FUNCTION; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FIBROBLAST; GENOME; HUMAN; HUMAN CELL; IMMUNE RESPONSE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY; UPREGULATION; AMINO ACID SEQUENCE; CELL CULTURE; CELL STRAIN CACO 2; CELL STRAIN HT29; CHEMISTRY; DNA RESPONSIVE ELEMENT; GENETICS; HELA CELL; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; PROTEIN BINDING; PROTEIN TERTIARY STRUCTURE; TUMOR CELL LINE; VIROLOGY;

AMINO ACID SEQUENCE; CACO-2 CELLS; CELL LINE, TUMOR; CELLS, CULTURED; CYTOMEGALOVIRUS; FIBROBLASTS; HELA CELLS; HT29 CELLS; HUMANS; INTERFERON-GAMMA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR SEQUENCE DATA; OLIGODEOXYRIBONUCLEOTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; RESPONSE ELEMENTS; SIGNAL TRANSDUCTION;

EID: 77949897797     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900557     Document Type: Article

References (43)

1. Ting, J. P.-Y., and B. K. Davis. 2005. CATERPILLER: a novel gene family important in immunity, cell death, and diseases. Annu. Rev. Immunol. 23: 387-414.
2. Inohara, N., and G. Nuñez. 2003. NODs: intracellular proteins involved in inflammation and apoptosis. Nat. Rev. Immunol. 3: 371-382.
3. Inohara, N., T. Koseki, J. Lin, L. del Peso, P. C. Lucas, F. F. Chen, Y. Ogura, and G. Núñez. 2000. An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways. J. Biol. Chem. 275: 27823-27831.
4. Franchi, L., N. Warner, K. Viani, and G. Nuñez. 2009. Function of Nod-like receptors in microbial recognition and host defense. Immunol. Rev. 227: 106-128.
5. Ting, J. P., and K. L. Williams. 2005. The CATERPILLER family: an ancient family of immune/apoptotic proteins. Clin. Immunol. 115: 33-37.
6. Creagh, E. M., and L. A. J. O'Neill. 2006. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol. 27: 352-357.
7. Hugot, J. P., M. Chamaillard, H. Zouali, S. Lesage, J. P. Cézard, J. Belaiche, S. Almer, C. Tysk, C. A. O'Morain, M. Gassull, et al. 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599-603.
8. Ogura, Y., D. K. Bonen, N. Inohara, D. L. Nicolae, F. F. Chen, R. Ramos, H. Britton, T. Moran, R. Karaliuskas, R. H. Duerr, et al. 2001. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411: 603-606.
9. Hampe, J., A. Cuthbert, P. J. Croucher, M. M. Mirza, S. Mascheretti, S. Fisher, H. Frenzel, K. King, A. Hasselmeyer, A. J. MacPherson, et al. 2001. Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357: 1925-1928.
10. Miceli-Richard, C., S. Lesage, M. Rybojad, A. M. Prieur, S. Manouvrier-Hanu, R. Häfner, M. Chamaillard, H. Zouali, G. Thomas, and J. P. Hugot. 2001. CARD15 mutations in Blau syndrome. Nat. Genet. 29: 19-20.
11. Kastner, D. L., and J. J. O'Shea. 2001. A fever gene comes in from the cold. Nat. Genet. 29: 241-242.
12. Hoffman, H. M., J. L. Mueller, D. H. Broide, A. A. Wanderer, and R. D. Kolodner. 2001. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat. Genet. 29: 301-305.
13. Feldmann, J., A. M. Prieur, P. Quartier, P. Berquin, S. Certain, E. Cortis, D. Teillac-Hamel, A. Fischer, and G. de Saint Basile. 2002. Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am. J. Hum. Genet. 71: 198-203.
14. Villani, A. C., M. Lemire, G. Fortin, E. Louis, M. S. Silverberg, C. Collette, N. Baba, C. Libioulle, J. Belaiche, A. Bitton, et al. 2009. Common variants in the NLRP3 region contribute to Crohn's disease susceptibility. Nat. Genet. 41: 71-76.
15. Jin, Y., C. M. Mailloux, K. Gowan, S. L. Riccardi, G. LaBerge, D. C. Bennett, P. R. Fain, and R. A. Spritz. 2007. NALP1 in vitiligo-associated multiple autoimmune disease. N. Engl. J. Med. 356: 1216-1225.
16. Till, A., P. Rosenstiel, K. Bräutigam, C. Sina, G. Jacobs, H. H. Oberg, D. Seegert, T. Chakraborty, and S. Schreiber. 2008. A role for membrane-bound CD147 in NOD2-mediated recognition of bacterial cytoinvasion. J. Cell Sci. 121: 487-495.
17. Hobom, U., W. Brune, M. Messerle, G. Hahn, and U. H. Koszinowski. 2000. Fast screening procedures for random transposon libraries of cloned herpesvirus genomes: mutational analysis of human cytomegalovirus envelope glycoprotein genes. J. Virol. 74: 7720-7729.
18. Schierling, K., C. Buser, T. Mertens, and M. Winkler. 2005. Human cytomegalovirus tegument protein ppUL35 is important for viral replication and particle formation. J. Virol. 79: 3084-3096.
19. Hirata, Y., A. H. Broquet, L. Menchén, and M. F. Kagnoff. 2007. Activation of innate immune defense mechanisms by signaling through RIG-I/IPS-1 in intestinal epithelial cells. J. Immunol. 179: 5425-5432.
20. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
21. Albrecht, M., and F. L. W. Takken. 2006. Update on the domain architectures of NLRs and R proteins. Biochem. Biophys. Res. Commun. 339: 459-462.
22. Schindler, C., D. E. Levy, and T. Decker. 2007. JAK-STAT signaling: from interferons to cytokines. J. Biol. Chem. 282: 20059-20063.
23. Shuai, K., and B. Liu. 2003. Regulation of JAK-STAT signalling in the immune system. Nat. Rev. Immunol. 3: 900-911.
24. Platanias, L. C. 2005. Mechanisms of type-I- and type-II-interferon- mediated signalling. Nat. Rev. Immunol. 5: 375-386.
25. Katze, M. G., Y. He, and M. Gale. 2002. Viruses and interferon: a fight for supremacy. Nat. Rev. Immunol. 2: 675-687.
26. Inohara, N., T. Koseki, L. del Peso, Y. Hu, C. Yee, S. Chen, R. Carrio, J. Merino, D. Liu, J. Ni, and G. Núñez. 1999. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. J. Biol. Chem. 274: 14560-14567.
27. Ogura, Y., N. Inohara, A. Benito, F. F. Chen, S. Yamaoka, and G. Nunez. 2001. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J. Biol. Chem. 276: 4812-4818.
28. Girardin, S. E., R. Tournebize, M. Mavris, A. L. Page, X. Li, G. R. Stark, J. Bertin, P. S. DiStefano, M. Yaniv, P. J. Sansonetti, and D. J. Philpott. 2001. CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. EMBO Rep. 2: 736-742.
29. Chen, G., M. H. Shaw, Y. G. Kim, and G. Nuñez. 2009. NOD-like receptors: role in innate immunity and inflammatory disease. Annu. Rev. Pathol. 4: 365-398.
30. Wang, X., H. Kuivaniemi, G. Bonavita, L. Mutkus, U. Mau, E. Blau, N. Inohara, G. Nunez, G. Tromp, and C. J. Williams. 2002. CARD15 mutations in familial granulomatosis syndromes: a study of the original Blau syndrome kindred and other families with large-vessel arteritis and cranial neuropathy. Arthritis Rheum. 46: 3041-3045.
31. Aganna, E., F. Martinon, P. N. Hawkins, J. B. Ross, D. C. Swan, D. R. Booth, H. J. Lachmann, A. Bybee, R. Gaudet, P. Woo, et al. 2002. Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum. 46: 2445-2452.
32. Aksentijevich, I., M. Nowak, M. Mallah, J. J. Chae, W. T. Watford, S. R. Hofmann, L. Stein, R. Russo, D. Goldsmith, P. Dent, et al. 2002. De novo CIAS1 mutations, cytokine activation, and evidence for genetic heterogeneity in patients with neonatal-onset multisystem inflammatory disease (NOMID): a new member of the expanding family of pyrin-associated autoinflammatory diseases. Arthritis Rheum. 46: 3340-3348.
33. Mathews, R. J., M. B. Sprakes, and M. F. McDermott. 2008. NOD-like receptors and inflammation. Arthritis Res. Ther. 10: 228.
34. Benko, S., D. J. Philpott, and S. E. Girardin. 2008. The microbial and danger signals that activate Nod-like receptors. Cytokine 43: 368-373.
35. Martinon, F., V. Pétrilli, A. Mayor, A. Tardivel, and J. Tschopp. 2006. Goutassociated uric acid crystals activate the NALP3 inflammasome. Nature 440: 237-241.
36. Harada, H., M. Matsumoto, M. Sato, Y. Kashiwazaki, T. Kimura, M. Kitagawa, T. Yokochi, R. S. Tan, T. Takasugi, Y. Kadokawa, et al. 1996. Regulation of IFN-alpha/ beta genes: evidence for a dual function of the transcription factor complex ISGF3 in the production and action of IFN-alpha/beta. Genes Cells 1: 995-1005.
37. Gale, M., Jr., C. M. Blakely, D. A. Hopkins, M. W. Melville, M. Wambach, P. R. Romano, and M. G. Katze. 1998. Regulation of interferon-induced protein kinase PKR: modulation of P58IPK inhibitory function by a novel protein, P52rIPK. Mol. Cell. Biol. 18: 859-871.
38. Inohara, N., and G. Nuñez. 2001. The NOD: a signaling module that regulates apoptosis and host defense against pathogens. Oncogene 20: 6473-6481.
39. Chamaillard, M., M. Hashimoto, Y. Horie, J. Masumoto, S. Qiu, L. Saab, Y. Ogura, A. Kawasaki, K. Fukase, S. Kusumoto, et al. 2003. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol. 4: 702-707.
40. Bonen, D. K., Y. Ogura, D. L. Nicolae, N. Inohara, L. Saab, T. Tanabe, F. F. Chen, S. J. Foster, R. H. Duerr, S. R. Brant, et al. 2003. Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology 124: 140-146.
41. Moore, C. B., D. T. Bergstralh, J. A. Duncan, Y. Lei, T. E. Morrison, A. G. Zimmermann, M. A. Accavitti-Loper, V. J. Madden, L. Sun, Z. Ye, et al. 2008. NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 451: 573-577.
42. Tattoli, I., L. A. Carneiro, M. Jehanno, J. G. Magalhaes, Y. Shu, D. J. Philpott, D. Arnoult, and S. E. Girardin. 2008. NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-kappaB and JNK pathways by inducing reactive oxygen species production. EMBO Rep. 9: 293-300.
43. Ichinohe, T., H. K. Lee, Y. Ogura, R. Flavell, and A. Iwasaki. 2009. Inflammasome recognition of influenza virus is essential for adaptive immune responses. J. Exp. Med. 206: 79-87.